BlackRock
ORTX

BlackRock’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

BlackRock’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-71,200
Closed -$356K – 5873
2022
Q3 		$356K Sell
71,200
-2,155
-3% -$12K ﹤0.01% 4823
2022
Q2 		$429K Sell
73,355
-1,644
-2% -$9.28K ﹤0.01% 4816
2022
Q1 		$534K Buy
74,999
+12,448
+20% +$122K ﹤0.01% 4848
2021
Q4 		$826K Sell
62,551
-2,732
-4% -$45.2K ﹤0.01% 4730
2021
Q3 		$1.5M Sell
65,283
-2,289
-3% -$68.1K ﹤0.01% 4435
2021
Q2 		$2.97M Buy
67,572
+14,835
+28% +$826K ﹤0.01% 4104
2021
Q1 		$3.83M Sell
52,737
-1,060
-2% -$75.3K ﹤0.01% 4060
2020
Q4 		$2.32M Sell
53,797
-16,553
-24% -$741K ﹤0.01% 3989
2020
Q3 		$2.89M Sell
70,350
-640
-0.9% -$33.1K ﹤0.01% 3795
2020
Q2 		$4.26M Buy
70,990
+34,915
+97% +$3.2M ﹤0.01% 3588
2020
Q1 		$2.72M Sell
36,075
-1,719
-5% -$198K ﹤0.01% 3568
2019
Q4 		$5.2M Buy
+37,794
New +$4.6M ﹤0.01% 3485
2019
Q3 		– Sell
-5,259
Closed -$736K – 5110
2019
Q2 		$736K Buy
+5,259
New +$923K ﹤0.01% 4105

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock's ORTX Position: Q4 2022 in Review

BlackRock sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2022, closing a stake of 71,200 shares — an estimated $356K sold.

BlackRock first reported a position in ORTX in Q2 2019 and held it in 13 quarters. The position peaked at $5.2M in Q4 2019. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2022.

  • BlackRock reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • BlackRock sold 71,200 Orchard Therapeutics plc American Depositary Shares shares in Q4 2022, an estimated $356K.
  • BlackRock first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 13 quarters.
  • BlackRock's Orchard Therapeutics plc American Depositary Shares position peaked at $5.2M in Q4 2019.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.